Skip to content
GLP-1 Scorecard
Menu
Site position #301

NativeMed

Published by GLP-1 ScorecardUpdated

NativeMed, LLC (nativemed.net) is a Miami, FL-based cash-pay telehealth provider offering compounded semaglutide at promotional $149/mo (regular $299) and compounded tirzepatide at promotional $183/mo (regular $399), plus NAD+ and several non-weight-loss generics.

Visit NativeMedWe may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Semaglutide
$149/mo (promotional rate, compounded)
Tirzepatide
$183/mo (promotional rate, compounded)
Coverage
Coverage not published
Brand-name
Not confirmed

Weigh NativeMed against the full graded field on the best semaglutide providers scorecard, or line it up against its closest alternatives. If you are considering a compounded option, read about whether compounded semaglutide is legit and safe.

Factor breakdown

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and policies may differ from those used in the marks. See the methodology.

Cost value74/100
Dose & formulation64/100
Clinical oversight55/100
Labs & monitoring53/100
Fulfillment67/100
Contract terms55/100

Strengths

  • LegitScript Certified (verifiable in the footer)
  • Promotional pricing shown publicly: $149/mo semaglutide, $183/mo tirzepatide
  • Online questionnaire intake, with a live visit added when state law requires it

What to consider

  • Pharmacy partners aren't named — described only as 'USA-based' or 'accredited' pharmacies
  • States served aren't listed publicly
  • Prices are promotional — confirm whether they hold past month one or rise to the $299/$399 regular rate
  • FDA issued NativeMed LLC dba NativeMed a warning letter in June 2026; the letter is public in FDA's warning-letter database

Bottom line — Grade C

Best for: Shoppers who want sub-$200 promotional compounded GLP-1 pricing.

Site position #301 of 541. Commercial relationships affect placement, not the score. See our featured provider, CoreAge Rx (#1), for comparison.

FDAWarning letter issued to NativeMed LLC dba NativeMed in June 2026. See the FDA warning-letter database.

Visit NativeMed

Closest here

The rankings grading nearest NativeMed — the realistic shortlist.

Claya#298

Claya is a direct-to-consumer telehealth platform offering compounded semaglutide and tirzepatide in both injectable and oral-tablet forms — a wider format range than most competitors.

EOS Health#299

EOS Health is a multi-vertical online telehealth service (weight loss, longevity, men's/women's health, skincare) offering compounded GLP-1 programs.

Walgreens Weight Management#300

Walgreens offers branded weight-loss care at $49 per visit without a required subscription. Medication is separate, with prior-authorization support now advertised for eligible commercially insured patients.

JRNYS#302

JRNYS is a telehealth weight-loss membership built around branded GLP-1 medications, and the membership itself buys no medication.

LVNG RX#303

LVNG RX is a Delaware-registered telehealth platform (LVNG RX LLC) offering compounded semaglutide from $149/mo and tirzepatide from $249/mo, plus a lower-dose GLP-1 microdose program.

Somira Health#304

Somira Health is a self-pay telehealth platform that connects you with independent licensed providers and compounding pharmacies for GLP-1 weight loss.

The 21 rankings nearest this one

View full scorecard rankings →

Pricing/verification reflect NativeMed's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on NativeMed's site. Not medical advice; see our disclosure.

← Back to the scorecard